The Eluvia Drug-Eluting Stent System continues to demonstrate unprecedented clinical outcomes with a 92.5% freedom from TLR at 2 years, the highest reported in comparable SFA clinical trials.
The FLEXIVEᵀᴹ Cobalt-Chromium Endovascular Stent System is the new treatment option for tortuous iliac lesions. This highly visible Cobalt Chromium stent with thin struts is designed to provide outstanding flexibility and conformability.
The Innova™ Self-Expanding Stent System introduces a new level of performance in SFA stenting, with an optimal combination of superb flexibility, high radial force, significantly reduced fracture rates and excellent deliverability.¹
The PROMUS Element Plus Stent System establishes a new standard of drug-eluting stent performance with the combination of its highly visible Platinum Chromium alloy and innovative stent design for a superior compression resistance together with the market-leading Everolimus drug.